A new collaborative study from researchers reveals
unexpected insights into how skin exposure to
ultraviolet (UV) light can worsen clinical symptoms
in autoimmune diseases such as lupus. Lupus, an
autoimmune disease that can cause inflammation of
the joints, skin, kidneys, blood cells, brain, heart
and lungs, is caused when the immune system attacks
its own tissue. Previous research has established
that in up to 80 percent of lupus patients, sunlight
exposure can trigger both local skin inflammation
and systemic flares, including kidney disease. But
little has been understood about the underlying
mechanisms that drive this process. In the study,
the researchers looked for markers of inflammation
and injury in the skin, the blood, and the kidney at
different time points following UV light exposure in
mice & able to demonstrate that neutrophils not only
infiltrated the UV light-exposed skin, but also
dispersed throughout the circulatory system and
migrated to the kidney. Interestingly, one subset of
these neutrophils, the ones that researcher think
are more damaging, first went to the skin that was
exposed to the UV light and then turned around and
went to the kidney. The investigators found that a
single exposure of skin to UV light stimulates
inflammatory and injury processes in the kidney,
including transient proteinuria, even in normal,
healthy mice. To be clear, normal, healthy mice
don't get the clinical type of kidney disease that
present in lupus patients. Researcher said that the
mice recover and are fine afterwards & this
subclinical injury may lead to pathologic
consequences in the vulnerable setting of
pre-existing inflammation in lupus patients, and
lead to kidney disease flare after exposure to
sunlight. Importantly, the inflammatory and injury
markers they detected in the mouse kidneys following
UV light exposure were very similar to the renal
injury markers that are associated with more severe
kidney damage in lupus patients. In addition, the
exposure to UV light also triggered an immune
response that is often expressed in most lupus
patients the type 1 interferon response in both the
skin and kidney. |